IBDEI0Q5 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34608,2)
 ;;=^5015760
 ;;^UTILITY(U,$J,358.3,34609,0)
 ;;=N52.39^^100^1503^40
 ;;^UTILITY(U,$J,358.3,34609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34609,1,3,0)
 ;;=3^Erectile Dysfunction Post-Surgical
 ;;^UTILITY(U,$J,358.3,34609,1,4,0)
 ;;=4^N52.39
 ;;^UTILITY(U,$J,358.3,34609,2)
 ;;=^5015761
 ;;^UTILITY(U,$J,358.3,34610,0)
 ;;=N52.33^^100^1503^39
 ;;^UTILITY(U,$J,358.3,34610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34610,1,3,0)
 ;;=3^Erectile Dysfunction Following Urethral Surgery
 ;;^UTILITY(U,$J,358.3,34610,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,34610,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,34611,0)
 ;;=N52.32^^100^1503^36
 ;;^UTILITY(U,$J,358.3,34611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34611,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,34611,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,34611,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,34612,0)
 ;;=N52.31^^100^1503^37
 ;;^UTILITY(U,$J,358.3,34612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34612,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,34612,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,34612,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,34613,0)
 ;;=N52.2^^100^1503^43
 ;;^UTILITY(U,$J,358.3,34613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34613,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,34613,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,34613,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,34614,0)
 ;;=N52.03^^100^1503^34
 ;;^UTILITY(U,$J,358.3,34614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34614,1,3,0)
 ;;=3^Erectile Dysfunction Comb Artrl Insuff & Corporo-Venous Occlusv
 ;;^UTILITY(U,$J,358.3,34614,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,34614,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,34615,0)
 ;;=N52.02^^100^1503^35
 ;;^UTILITY(U,$J,358.3,34615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34615,1,3,0)
 ;;=3^Erectile Dysfunction Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,34615,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,34615,2)
 ;;=^5015753
 ;;^UTILITY(U,$J,358.3,34616,0)
 ;;=N52.1^^100^1503^42
 ;;^UTILITY(U,$J,358.3,34616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34616,1,3,0)
 ;;=3^Erectile Dysfunction d/t Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,34616,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,34616,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,34617,0)
 ;;=N52.01^^100^1503^41
 ;;^UTILITY(U,$J,358.3,34617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34617,1,3,0)
 ;;=3^Erectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,34617,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,34617,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,34618,0)
 ;;=N95.2^^100^1503^81
 ;;^UTILITY(U,$J,358.3,34618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34618,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,34618,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,34618,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,34619,0)
 ;;=R30.9^^100^1503^65
 ;;^UTILITY(U,$J,358.3,34619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34619,1,3,0)
 ;;=3^Micturition Painful,Unspec
 ;;^UTILITY(U,$J,358.3,34619,1,4,0)
 ;;=4^R30.9
 ;;^UTILITY(U,$J,358.3,34619,2)
 ;;=^5019324
 ;;^UTILITY(U,$J,358.3,34620,0)
 ;;=R30.0^^100^1503^26
 ;;^UTILITY(U,$J,358.3,34620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34620,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,34620,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,34620,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,34621,0)
 ;;=R33.9^^100^1503^105
 ;;^UTILITY(U,$J,358.3,34621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34621,1,3,0)
 ;;=3^Urine Retention,Unspec
 ;;^UTILITY(U,$J,358.3,34621,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,34621,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,34622,0)
 ;;=R32.^^100^1503^103
 ;;^UTILITY(U,$J,358.3,34622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34622,1,3,0)
 ;;=3^Urinary Incontinence,Unspec
 ;;^UTILITY(U,$J,358.3,34622,1,4,0)
 ;;=4^R32.
 ;;^UTILITY(U,$J,358.3,34622,2)
 ;;=^5019329
 ;;^UTILITY(U,$J,358.3,34623,0)
 ;;=N39.41^^100^1503^101
 ;;^UTILITY(U,$J,358.3,34623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34623,1,3,0)
 ;;=3^Urge Incontinence
 ;;^UTILITY(U,$J,358.3,34623,1,4,0)
 ;;=4^N39.41
 ;;^UTILITY(U,$J,358.3,34623,2)
 ;;=^5015680
 ;;^UTILITY(U,$J,358.3,34624,0)
 ;;=R35.0^^100^1503^63
 ;;^UTILITY(U,$J,358.3,34624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34624,1,3,0)
 ;;=3^Micturition Frequency
 ;;^UTILITY(U,$J,358.3,34624,1,4,0)
 ;;=4^R35.0
 ;;^UTILITY(U,$J,358.3,34624,2)
 ;;=^5019334
 ;;^UTILITY(U,$J,358.3,34625,0)
 ;;=R35.1^^100^1503^73
 ;;^UTILITY(U,$J,358.3,34625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34625,1,3,0)
 ;;=3^Nocturia
 ;;^UTILITY(U,$J,358.3,34625,1,4,0)
 ;;=4^R35.1
 ;;^UTILITY(U,$J,358.3,34625,2)
 ;;=^5019335
 ;;^UTILITY(U,$J,358.3,34626,0)
 ;;=R39.11^^100^1503^64
 ;;^UTILITY(U,$J,358.3,34626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34626,1,3,0)
 ;;=3^Micturition Hesitancy
 ;;^UTILITY(U,$J,358.3,34626,1,4,0)
 ;;=4^R39.11
 ;;^UTILITY(U,$J,358.3,34626,2)
 ;;=^5019341
 ;;^UTILITY(U,$J,358.3,34627,0)
 ;;=R39.16^^100^1503^95
 ;;^UTILITY(U,$J,358.3,34627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34627,1,3,0)
 ;;=3^Straining to Void
 ;;^UTILITY(U,$J,358.3,34627,1,4,0)
 ;;=4^R39.16
 ;;^UTILITY(U,$J,358.3,34627,2)
 ;;=^5019346
 ;;^UTILITY(U,$J,358.3,34628,0)
 ;;=R36.0^^100^1503^97
 ;;^UTILITY(U,$J,358.3,34628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34628,1,3,0)
 ;;=3^Urethral Discharge w/o Blood
 ;;^UTILITY(U,$J,358.3,34628,1,4,0)
 ;;=4^R36.0
 ;;^UTILITY(U,$J,358.3,34628,2)
 ;;=^5019337
 ;;^UTILITY(U,$J,358.3,34629,0)
 ;;=R36.9^^100^1503^98
 ;;^UTILITY(U,$J,358.3,34629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34629,1,3,0)
 ;;=3^Urethral Discharge,Unspec
 ;;^UTILITY(U,$J,358.3,34629,1,4,0)
 ;;=4^R36.9
 ;;^UTILITY(U,$J,358.3,34629,2)
 ;;=^5019338
 ;;^UTILITY(U,$J,358.3,34630,0)
 ;;=R97.2^^100^1503^27
 ;;^UTILITY(U,$J,358.3,34630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34630,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,34630,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,34630,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,34631,0)
 ;;=R80.1^^100^1503^87
 ;;^UTILITY(U,$J,358.3,34631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34631,1,3,0)
 ;;=3^Proteinuria Persistent,Unspec
 ;;^UTILITY(U,$J,358.3,34631,1,4,0)
 ;;=4^R80.1
 ;;^UTILITY(U,$J,358.3,34631,2)
 ;;=^5019596
 ;;^UTILITY(U,$J,358.3,34632,0)
 ;;=R80.0^^100^1503^85
 ;;^UTILITY(U,$J,358.3,34632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34632,1,3,0)
 ;;=3^Proteinuria Isolated
 ;;^UTILITY(U,$J,358.3,34632,1,4,0)
 ;;=4^R80.0
 ;;^UTILITY(U,$J,358.3,34632,2)
 ;;=^5019595
 ;;^UTILITY(U,$J,358.3,34633,0)
 ;;=R80.8^^100^1503^88
 ;;^UTILITY(U,$J,358.3,34633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34633,1,3,0)
 ;;=3^Proteinuria,Other
 ;;^UTILITY(U,$J,358.3,34633,1,4,0)
 ;;=4^R80.8
 ;;^UTILITY(U,$J,358.3,34633,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,34634,0)
 ;;=R80.3^^100^1503^84
 ;;^UTILITY(U,$J,358.3,34634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34634,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,34634,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,34634,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,34635,0)
 ;;=R80.9^^100^1503^89
 ;;^UTILITY(U,$J,358.3,34635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34635,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,34635,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,34635,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,34636,0)
 ;;=Z87.442^^100^1503^77
 ;;^UTILITY(U,$J,358.3,34636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34636,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,34636,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,34636,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,34637,0)
 ;;=N18.1^^100^1503^13
 ;;^UTILITY(U,$J,358.3,34637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34637,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,34637,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,34637,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,34638,0)
 ;;=N18.2^^100^1503^14
 ;;^UTILITY(U,$J,358.3,34638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34638,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,34638,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,34638,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,34639,0)
 ;;=N18.3^^100^1503^15
 ;;^UTILITY(U,$J,358.3,34639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34639,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,34639,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,34639,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,34640,0)
 ;;=N18.4^^100^1503^16
 ;;^UTILITY(U,$J,358.3,34640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34640,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,34640,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,34640,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,34641,0)
 ;;=N18.5^^100^1503^17
 ;;^UTILITY(U,$J,358.3,34641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34641,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,34641,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,34641,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,34642,0)
 ;;=Q61.3^^100^1503^80
 ;;^UTILITY(U,$J,358.3,34642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34642,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,34642,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,34642,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,34643,0)
 ;;=N20.1^^100^1503^9
 ;;^UTILITY(U,$J,358.3,34643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34643,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,34643,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,34643,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,34644,0)
 ;;=N18.9^^100^1503^18
 ;;^UTILITY(U,$J,358.3,34644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34644,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,34644,1,4,0)
 ;;=4^N18.9
